The MarketWatch News Department was not involved in the creation of this content.-- Raised over $20 million in gross proceeds in 2025 and held $11.9 million in cash and cash equiv ...

As pharmaceutical companies lean more heavily on A.I. to accelerate drug discovery, model biological interactions and ...

AI agents reshape security operations by reducing analyst burden and accelerating threat response. But organizations face a surge in AI-driven attacks, which ...

Unmasking impostors is something the art world has faced for decades, and there are valuable lessons from the works of Elmyr ...

Objective Postmarketing safety data of avacopan, the first Food and Drug Administration (FDA) approved drug in a decade for ...

Part three of this three-part series on justifying improved control via economics shows how simulation can quantify reduced ...

For organisations pursuing SOC 2, demonstrating effective security controls is central to the audit process. While the framework does not prescribe specific technologies or testing frequencies, it ...

The reason agentic AI has seen slow enterprise adoption is the lack of an orchestration layer to track what agents are doing, ...

We've moved past the era of "ChatGPT wrappers" (thank God), but the industry still treats autonomous agents like they're just ...

We know that the RSAC 2026 cybersecurity conference this week in San Francisco is going to be an artificial ...

Security operations rarely fail because of a lack of tools. They fail because the operating model never kept pace with the ...

Hospitals rely on medical technology vendors for everything from imaging systems and infusion pumps to EHR integrations and remote monitoring ...